RxDoctor Payments DataLook up a doctor →

William Allan, MD

Internal Medicine · Wheat Ridge, CONPI 1932272713

Payments from drug & device makers

$12,640in general payments, 2019–2025

Across 735 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • GSK$1K
  • Pfizer$860
  • Lilly USA, LLC$840
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$12,628100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)71$1,315
Novo Nordisk70$1,203
AstraZeneca(2 entities)64$1,151
GSK54$1,023
Pfizer55$860
Lilly USA, LLC61$840
Boehringer Ingelheim49$812
Johnson & Johnson51$798
Amgen(2 entities)26$494
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$335
E.r. Squibb & Sons, L.L.C.13$298
Bayer14$246
Astellas Pharma US Inc12$239
Aimmune Therapeutics, Inc.12$223
Nestle Healthcare Nutrition Inc.17$220
Merck14$200
Biohaven Pharmaceutical Holding Company Ltd.7$189
Novartis11$189
Grifols USA, LLC9$183
Sanofi-aventis U.S. LLC13$158
Amarin Pharma, Inc.9$148
Kowa Pharmaceuticals America, Inc.9$128
Biohaven Pharmaceuticals, Inc.6$117
Radius Health, Inc.5$103
Medtronic(3 entities)5$97
Sumitomo Pharma America, Inc.4$85
Otsuka America Pharmaceutical, Inc.3$66
Sunovion Pharmaceuticals Inc.3$59
Dexcom, Inc.3$57
Nevro Corp.3$50
Abbott2$48
Seqirus USA Inc3$46
Xeris Pharmaceuticals, Inc.2$44
Esperion Therapeutics, Inc.3$44
Gilead2$43
Boston Scientific1$39
Dermira, Inc.2$36
Avanir Pharmaceuticals, Inc.2$33
Amphastar Pharmaceuticals, Inc.1$31
Exact Sciences1$30
Daiichi Sankyo Inc.2$26
Impulse Dynamics (USA) Inc.1$24
Kyowa Kirin, Inc.1$23
Averitas Pharma Inc.1$23
Lifescan, Inc.1$21
Melinta Therapeutics, LLC1$21
Teva Pharmaceuticals USA, Inc.1$21
Takeda Pharmaceuticals U.S.A., Inc.1$20
Lucid Diagnostics Inc.1$20
Vertiflex, Inc.1$18
Bausch Health US, LLC1$18
Idorsia Pharmaceuticals US Inc1$17
Eisai Inc.1$17
United Therapeutics Corporation1$16
IBSA Pharma Inc.1$16
Biogen1$16
Vertical Pharmaceuticals, LLC1$16
VBI Vaccine (delaware) Inc.1$15
Quidel Corporation1$14

How this compares

$12,640 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$219,902
Medicare patients
1,240
Services billed
29,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin104$129,130
EliquisApixaban102$97,751
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$68,930
OzempicSemaglutide66$67,706
TymlosAbaloparatide18$53,881
XareltoRivaroxaban35$45,147
FarxigaDapagliflozin Propanediol33$29,733
MounjaroTirzepatide22$27,901
MyrbetriqMirabegron14$19,521
GemtesaVibegron24$19,105
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$16,785
TrulicityDulaglutide14$15,956
RybelsusSemaglutide14$14,917
SymbicortBudesonide/Formoterol Fumarate15$10,389
ArexvyRsvpref3 Antigen/As01e/Pf33$10,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$812$129,130104 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Shingrix, Anoro Ellipta$1,023$103,781181 claims
PfizerEliquis$860$97,751102 claims
Novo NordiskOzempic, Rybelsus$1,203$82,62380 claims
Radius Health, Inc.Tymlos$103$53,88118 claims
Johnson & JohnsonXarelto$798$45,14735 claims
Lilly USA, LLCMounjaro, Trulicity$840$43,85736 claims
AstraZenecaFarxiga, Symbicort$1,151$40,12148 claims
Astellas Pharma US IncMyrbetriq$239$19,52114 claims
Sumitomo Pharma America, Inc.Gemtesa$85$19,10524 claims
MerckBelsomra$200$5,24412 claims
AbbVieSynthroid$1,315$2,81248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Wheat Ridge

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →